Infection rates are higher in type 1 diabetes

Compared with control subjects without diabetes, adults with diabetes had higher rates for all infections, with the highest incidence seen for bone and joint infections, sepsis, and cellulitis. Particularly type 1 diabetes patients are at increased risk of serious infection, representing an important population burden. Strategies that reduce the risk of developing severe infections should be explored.

D.Care

 


Diabetes Care

Retrospective

January 2018

 

OBJECTIVE

We describe in detail the burden of infections in adults with diabetes within a large national population cohort. We also compare infection rates between patients with type 1 and type 2 diabetes mellitus (T1DM and T2DM).

 

RESEARCH DESIGN AND METHODS

A retrospective cohort study compared 102,493 English primary care patients aged 40–89 years with a diabetes diagnosis by 2008 (n = 5,863 T1DM and n = 96,630 T2DM) with 203,518 age-sex-practice–matched control subjects without diabetes.

Infection rates during 2008–2015, compiled from primary care and linked hospital and mortality records, were compared across 19 individual infection categories. These were further summarized as any requiring a prescription or hospitalization or as cause of death. Poisson regression was used to estimate incidence rate ratios (IRRs) between 1) people with diabetes and control subjects and 2) T1DM and T2DM adjusted for age, sex, smoking, BMI, and deprivation.

 

RESULTS 

Compared with control subjects without diabetes, patients with diabetes had higher rates for all infections, with the highest IRRs seen for bone and joint infections, sepsis, and cellulitis.

IRRs for infection-related hospitalizations were 3.71 for T1DM and 1.88 for T2DM (both with p<0.05). A direct comparison of types confirmed higher adjusted risks for T1DM versus T2DM (death from infection IRR 2.19, p<0.05).

We estimate that 6% of infection-related hospitalizations and 12% of infection-related deaths were attributable to diabetes.

 

CONCLUSIONS 

People with diabetes, particularly T1DM, are at increased risk of serious infection, representing an important population burden. Strategies that reduce the risk of developing severe infections and poor treatment outcomes are under-researched and should be explored.